Drug-Coated Stents Face Further Scrutiny

Law360, New York (November 30, 2006, 12:00 AM EST) -- With a Food and Drug Administration advisory panel set to examine drug-coated stents at an upcoming meeting, a report has shown that the devices increase the risk of life-threatening blood clots in patients with coronary artery disease by four or five times that of bare-metal stents.

The analysis, which was released Wednesday by the Cleveland Clinic, added to the growing body of evidence that drug-coated stents potentially trigger more heart attacks than their older and cheaper bare-metal counterparts.

“Our analysis found there is a small, but...
To view the full article, register now.